Medication info
Minis Tablet 0.1 mg (Desmopressin Acetate)

Minis Tablet 0.1 mg (Desmopressin Acetate)

Prescription medicationTabletOral
Ingredient · strength
Desmopressin Acetate›0.1mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201902860 · Approved 2019.05.02 · Insurance code 628901280

Summary

Main use
Treatment of primary nocturnal enuresis (age 5 years and older) and nocturia associated with nocturnal polyuria (adults)
Who takes it
Adults · Children
Adult dose
Treatment of nocturia associated with nocturnal polyuria (adults only) : Administer 0.1mg of desmopressin acetate orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg; if the effect remains insufficient, the dose may be increased at one-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after determining the dose. Initiation of treatment with this medicine is not recommended in patients aged 65 years or older. In elderly patients who require treatment, closely monitor serum sodium levels, etc. (See section 5. General Precautions in Precautions for Use.)
Child dose
Primary nocturnal enuresis (aged 5 years and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased up to 0.4mg. Whether to continue treatment should be determined after 3 months of administration, following a treatment-free period of at least 1 week.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of primary nocturnal enuresis (age 5 years and older) and nocturia associated with nocturnal polyuria (adults)

  • Primary nocturnal enuresis
  • nocturnal enuresis symptoms
View approved original text

This medication is used for the treatment of nocturnal enuresis related to primary nocturnal enuresis in children over 5 years of age and nocturia in adults.

How to take

Adult dose

Treatment of nocturia associated with nocturnal polyuria (adults only) : Administer 0.1mg of desmopressin acetate orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg; if the effect remains insufficient, the dose may be increased at one-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after determining the dose. Initiation of treatment with this medicine is not recommended in patients aged 65 years or older. In elderly patients who require treatment, closely monitor serum sodium levels, etc. (See section 5. General Precautions in Precautions for Use.)

Child dose

Primary nocturnal enuresis (aged 5 years and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased up to 0.4mg. Whether to continue treatment should be determined after 3 months of administration, following a treatment-free period of at least 1 week.

Precautions

This medication can cause hyponatremia and fluid overload; therefore, elderly patients and those with certain medical conditions should be cautious and only drink water to the point of thirst. Patients with allergies to this medication, severe renal impairment, heart failure, or habitual excessive urine output should not take this medication. Extra caution should be taken when using this medication in patients with hypertension, cardiovascular diseases, chronic kidney diseases, pregnant women, children, and elderly patients. This medication can cause serious side effects such as coma, seizures, and weight gain, so if any unusual symptoms arise, immediate consultation with a physician is required. Fluid intake should be restricted for some time before and after taking this medication, as failure to comply may increase the risk of fluid retention or hyponatremia. This medication may interact with other drugs, so it is essential to inform healthcare providers about any current medications. Women who are pregnant or breastfeeding should carefully consider the effects on the fetus or infant before using this medication. In case of overdose, symptoms such as headache, nausea, seizures, and loss of consciousness may occur, so immediate medical treatment should be sought if any of these symptoms appear.

Side effects

  • coma
  • seizures
  • weight gain
  • hyponatremia
  • emotional disturbances
  • headache
  • abdominal pain
  • nausea
  • allergic skin reactions
  • dizziness
Show 8 more
  • peripheral edema
  • frequent urination
  • thirst
  • anaphylaxis
  • vomiting
  • weight increase
  • cold sensation
  • loss of consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.